Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A3B5 can reduce skin pigmentation and slow melanoma growth.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The new compound may be a safer alternative to finasteride for prostate protection.

Lowering 3α,5α-THP in the hippocampus increases anxiety and depression in proestrous rats.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Finasteride may help improve certain brain function issues linked to dopamine.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

GD-23 reduces anxiety by relying on neurosteroid production.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Blocking TRPV3 may help treat itch in dry skin conditions.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

A neurosteroid can reduce caffeine-induced anxiety in rats.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.